论文部分内容阅读
腹腔化疗是区域性化疗的一个重要措施,由于它能提高腹腔内化疗药物浓度而达到预防胃肠道恶性肿瘤根治术后腹腔内复发的目的。本院1996年6月～1998年6月开展腹腔化疗的临床研究,现就其并发症分析如下。1 临床资料1.1 一般资料:1996年6月至1998年6月对浆膜受侵的中晚期胃肠道恶
Intraperitoneal chemotherapy is an important measure of regional chemotherapy, because it can increase the concentration of intraperitoneal chemotherapeutic drugs to prevent intra-abdominal recurrence of gastrointestinal malignancy after radical resection. The clinical study of intraperitoneal chemotherapy was conducted in this hospital from June 1996 to June 1998. The complications are analyzed as follows. 1 Clinical data 1.1 General information: Middle and late gastrointestinal tract infections invaded by serosa from June 1996 to June 1998